M&A Deal Summary

Zymergen Acquires Lodo Therapeutics

On May 28, 2021, Zymergen acquired life science company Lodo Therapeutics

Acquisition Highlights
  • This is Zymergen’s 3rd transaction in the Life Science sector.
  • This is Zymergen’s 3rd transaction in the United States.
  • This is Zymergen’s 1st transaction in New York.

M&A Deal Summary

Date 2021-05-28
Target Lodo Therapeutics
Sector Life Science
Buyer(s) Zymergen
Deal Type Add-on Acquisition

Target

Lodo Therapeutics

New York, New York, United States
Lodo Therapeutics Corp. is a biotechnology company reinventing natural product drug discovery by applying its informatics-enabled technology platform to previously undruggable disease targets. Lodo Therapeutics was established in 2015 and is based in New York City.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zymergen

Emeryville, California, United States

Category Company
Founded 2013
Sector Information Technology
Revenue 17M USD (2021)
DESCRIPTION

Zymergen is a science and material innovation company rethinking biology and reimagining the world. The company partners with nature to create never-before-imagined materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more. It creates sustainable materials that are in use today, delivering value for Fortune 1000 companies with over $1 billion worth of products using Zymergen microbial innovations sold to date. Zymergen was formed in 2013 and is based in Emeryville, California.


DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 2 of 2
State (New York) 1 of 1
Country (United States) 3 of 3
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-19 enEvolv

Medford, Massachusetts, United States

enEvolv, Inc. is a synthetic biology company that develops an enzyme and strain development platform to harness the power of evolution and create unique, commercial products by engineering the genomes of microbes. enEvolv was established in 2011 and is based in Medford, Massachusetts.

Buy -